Skip to content
CancerIndex

Publication

Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer.

Authors not recorded

J Clin Pharmacol2016PMID 26313268PMC6361127stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (5)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 5

Curated evidence

Evidence citing this paper (2)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
26313268
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–2 of 2 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
UGT1A1 UGT1A1*281
BelinostatMalignant NeoplasmALIASPredictiveASupports Adverse Response5accepted
EID1792

The FDA approved package insert for Belinostat recommends dose adjustment for UGT1A1*28 allele homozygotes.

PMID 26313268 · Goey et al., 2016 · Open in CIViC

civic
UGT1A1 UGT1A1*601
BelinostatMalignant NeoplasmALIASPredictiveBSupports Adverse Response4accepted
EID1795

In a phase 1 trial belinostat (400-800mg/m2/24h) was administered to 25 patients in combination with cisplatin and etoposide. Endpoints were associations between genotype of UGT1A1 and pharmacokinetic… (full text at CIViC)

PMID 26313268 · Goey et al., 2016 · Open in CIViC

civic